4D Molecular Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Emeryville CA United States (2013)

Organization Overview

First Clinical Trial
2020
NCT04483440
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

4D, LLC | 4D Molecular Therapeutics